                      |
|
|
|
|||||
|
Use of CT Scans to
Diagnose Peripheral Vascular Disease Subject of New Training
Course Being Offered by
CVCTA Education and Toshiba
Course Will Help Teach Detection of Disease Affecting Twenty Million People |
|||||
July 5, 2007 -- TUSTIN, Calif. -- Strengthening its position as a leader in medical
education and improved patient care, Toshiba America Medical Systems,
Inc. today announced a partnership with CVCTA Education to provide
a Peripheral Vascular CTA (PV-CTA) training course. This course
will be the first of its kind to exceed current ACCF/AHA Level
2 requirements in the ACCF/AHA Clinical Competence Statement on
Cardiac Imaging with Computed Tomography and Magnetic Resonance.
Peripheral Vascular Disease (PVD) refers to diseases of the blood vessels outside
the heart and brain where there is a narrowing of vessels carrying
blood to the legs, arms, stomach and/or kidneys. The most common
type of PVD is Peripheral Arterial Disease (PAD) in which arteries
leading to these same regions develop blockages that restrict blood
circulation. PVD is common in patients predisposed to vascular
diseases, such as those suffering from diabetes. According to an
article in Cardiovascular Imaging, an estimated 20 million people
have PVD, with three to four million people going misdiagnosed
or untreated.
“PV-CTA is one of the most accurate and important non-invasive diagnostic tools
available to detect PVD in patients reporting symptoms and in those who are asymptomatic,” said
Doug Ryan, senior director, CT Business Unit. “Partnering with CVCTA Education
to offer a comprehensive PV-CTA educational course is a step toward ensuring
that PVD is properly detected and treated.”
The PV-CTA training course will be offered at CVCTA Training Centers in San Francisco,
New York and Houston, several times per month with the first course starting
in September. The course will use a blend of online learning and in-person training
on Toshiba’s leading Aquilion CT scanners. Students will complete six hours of
online didactics covering a review of anatomy and function, as well as findings
and reporting. Also, in one day of hands-on workstation training, the students
will be mentored on more than 25 cases of varying pathology. Students also will
work on more than 75 cases via CVCTA’s proprietary MedMind CTA training software.
Created by Dr. Peter Fail from the Cardiovascular Institute of the South and
Dr. Tony DeFrance from CVCTA, the PV-CTA course will provide students with more
than 100 mentored cases with a wide variety of pathology, therefore exceeding
the anticipated Level 2 requirements set by the ACCF and AHA. In total, the student
will receive 40 hours of CME credit.
“At CVCTA Education, we are committed to continually improving patient care by
offering state-of-the-art education to the medical community,” said Dr. Tony
DeFrance, Medical Director of CVCTA Education. “Additionally, PV-CTA will play
an important role in helping imaging centers and hospitals educate the community
on the emerging information and issues regarding the overall impact of PVD and
the value of this diagnostic tool.”
Additional information on the Toshiba’s PV-CTA course offered at CVCTA can be
found at www.medical.toshiba.com or www.cvcta.com.
About CVCTA
About Toshiba
Source: Toshiba America Medical Systems |
|||||
Angioplasty.Org Home • PatientCenter send comments & suggestions
to "info at angioplasty dot org" |
|||||